Therapeutic dosage assessment based on population pharmacokinetics of a novel single-dose transdermal donepezil patch in healthy volunteers

[1]  Hyeong-Seok Lim,et al.  Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteers , 2015, Drug design, development and therapy.

[2]  Matthias J. Müller,et al.  AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. , 2014, Pharmacopsychiatry.

[3]  Muriel Noetzli,et al.  Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance. , 2014, British journal of clinical pharmacology.

[4]  A. Banga,et al.  A novel electronic skin patch for delivery and pharmacokinetic evaluation of donepezil following transdermal iontophoresis. , 2013, International journal of pharmaceutics.

[5]  Y. Yamada,et al.  Population Pharmacokinetics of Transdermal Fentanyl in Patients With Cancer-Related Pain , 2012, Journal of pain & palliative care pharmacotherapy.

[6]  Matthias J. Müller,et al.  AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. , 2014, Pharmacopsychiatry.

[7]  T. Suhara,et al.  Estimation of Plasma IC50 of Donepezil for Cerebral Acetylcholinesterase Inhibition in Patients With Alzheimer Disease Using Positron Emission Tomography , 2010, Clinical neuropharmacology.

[8]  K. Bley,et al.  Pharmacokinetic Analysis of Capsaicin After Topical Administration of a High-Concentration Capsaicin Patch to Patients With Peripheral Neuropathic Pain , 2009, Therapeutic drug monitoring.

[9]  L. Ereshefsky,et al.  Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice‐daily Capsules in Alzheimer's Disease Patients , 2008, Clinical pharmacology and therapeutics.

[10]  W. Oertel,et al.  Rationale for transdermal drug administration in Alzheimer disease , 2007, Neurology.

[11]  B. Winblad,et al.  A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch versus capsule , 2007, International journal of geriatric psychiatry.

[12]  L. Minthon,et al.  Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer’s disease following chronic donepezil treatment , 2006, Journal of Neural Transmission.

[13]  Soo-Youn Lee,et al.  Sequence-based CYP2D6 Genotyping in the Korean Population , 2006, Therapeutic drug monitoring.

[14]  C. Perdomo,et al.  Steady-state pharmacokinetics, pharmacodynamics and tolerability of donepezil hydrochloride in hepatically impaired patients. , 2004, British journal of clinical pharmacology.

[15]  N. Relkin,et al.  A Large, Community-Based, Open-Label Trial of Donepezil in the Treatment of Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.

[16]  K. Någren,et al.  Regional Effects of Donepezil and Rivastigmine on Cortical Acetylcholinesterase Activity in Alzheimer’s Disease , 2002, Journal of clinical psychopharmacology.

[17]  Cooper,et al.  Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses: Multiple oral doses of donepezil , 2002 .

[18]  L. Friedhoff,et al.  Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses. , 2002, British journal of clinical pharmacology.

[19]  Dirk Deleu,et al.  A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. , 2001, Neurology.

[20]  B. Winblad,et al.  A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD , 2001, Neurology.

[21]  K. Hasegawa,et al.  Clinical Efficacy and Safety of Donepezil on Cognitive and Global Function in Patients with Alzheimer’s Disease , 2000, Dementia and Geriatric Cognitive Disorders.

[22]  L. Friedhoff,et al.  Pharmacokinetic and pharmacodynamic profile of donepezil HCl following evening administration. , 1998, British journal of clinical pharmacology.

[23]  L. Friedhoff,et al.  Metabolism and elimination of 14C-donepezil in healthy volunteers: a single-dose study. , 1998, British journal of clinical pharmacology.

[24]  L. Friedhoff,et al.  Concurrent administration of donepezil HCl and cimetidine: assessment of pharmacokinetic changes following single and multiple doses. , 1998, British journal of clinical pharmacology.

[25]  X. Tang,et al.  Comparative Studies of Huperzine A, E2020, and Tacrine on Behavior and Cholinesterase Activities , 1998, Pharmacology Biochemistry and Behavior.

[26]  E. Giacobini,et al.  The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex , 1996, Neuropharmacology.

[27]  A. Ohnishi,et al.  Comparison of the Pharmacokinetics of E2020, A New Compound for Alzheimer's Disease, in Healthy Young and Elderly Subjects , 1993, Journal of clinical pharmacology.

[28]  H. Owen,et al.  The efficacy of transdermal fentanyl in the treatment of postoperative pain: a double-blind comparison of fentanyl and placebo systems , 1990, Pain.

[29]  G. Flynn,et al.  Transdermal Delivery of Narcotic Analgesics: Comparative Permeabilities of Narcotic Analgesics Through Human Cadaver Skin , 1989, Pharmaceutical Research.

[30]  D. Stanski,et al.  Absorption characteristics of transdermally administered fentanyl. , 1989, Anesthesiology.

[31]  J. Plummer,et al.  The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects , 1989, Pain.

[32]  G. Small,et al.  Clinical Pharmacokinetics and Pharmacodynamics of Cholinesterase Inhibitors , 2002, Clinical pharmacokinetics.

[33]  L. Radbruch,et al.  Clinical Pharmacokinetics of Transdermal Opioids , 2000, Clinical pharmacokinetics.

[34]  L. Friedhoff,et al.  Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses. , 1998, British journal of clinical pharmacology.

[35]  L. Friedhoff,et al.  Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses. , 1998, British journal of clinical pharmacology.

[36]  E. Tur,et al.  Physiology of the skin--differences between women and men. , 1997, Clinics in dermatology.